To investigate the role of intracellular potassium (K-i)and other ions in h
ypertension and diabetes, we utilized K-39-, Na-23-, P-31-, and F-19-nuclea
r magnetic resonance (NMR) spectroscopy to measure K-i, intracellular sodiu
m (Na-i), intracellular free magnesium (Mg-i), and cytosolic free calcium (
Ca-i), respectively, in red blood cells of fasting normotensive nondiabetic
control subjects (n = 10), untreated (n = 13) and treated (n = 14) essenti
al hypertensive subjects, and diabetic subjects (n = 5). In 12 subjects (6
hypertensive and 6 normotensive controls), ions were also measured before a
nd after the acute infusion of 1 L of normal saline. Compared with those in
controls (K-i = 148 +/- 2.0 mmol/L), K-i levels were significantly lower i
n hypertensive (132.2 +/- 2.9 mmol/L, sig = 0.05) and in type 2 diabetic su
bjects (121.2 +/- 6.8 mmol/L, sig = 0.05). K-i was higher in treated hypert
ensives than in untreated hypertensives (139 +/- 3.1 mmol/L, sig = 0.05) bu
t was still lower than in normals. Although no significant relation was obs
erved between basal K-i and Na-i values, saline infusion elevated Na-i (P <
0.01) and reciprocally suppressed K-i levels (142 +/- 2.4 to 131 +/- 2.2 mm
ol/L, P <0.01). K-i was strongly and inversely related to Ca-i (r = -0.846,
P <0.001), and was directly related to Mg-i (r = 0.664, P <0.001). We conc
lude that (1) K-i depletion is a common feature of essential hypertension a
nd type 2 diabetes, (2) treatment of hypertension at least partially restor
es K-i levels toward normal, and (3) fasting steady-state K-i levels are cl
osely linked to Ca-i and Mg-i homeostasis. Altogether, these results emphas
ize the similar and coordinate nature of ionic defects in diabetes and hype
rtension and suggest that their interpretation requires an understanding of
their interaction.